Elena Tudor

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Francesca Conradie, Tatevik R. Bagdasaryan, Pauline Howell et al. · New England Journal of Medicine · 2022 · 507 citations · Full text

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 134 citations · Full text

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis, Tuberculosis Prevention +7

Genetic variation in TLR pathway and the risk of pulmonary tuberculosis in a Moldavian population

Alexander Varzari, Igor V. Deyneko, Iuri Vladei et al. · Infection Genetics and Evolution · 2018 · 29 citations · Full text

Polymorphisms of glutathione S-transferase and methylenetetrahydrofolate reductase genes in Moldavian patients with ulcerative colitis: Genotype-phenotype correlation

Alexander Varzari, Igor V. Deyneko, Elena Tudor et al. · Meta Gene · 2015 · 26 citations · Full text

Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial

Laura Roșu, Jason Madan, Ewan Tomeny et al. · The Lancet Global Health · 2022 · 17 citations · Full text